Spruce Biosciences Q2 EPS $(0.22) Beats $(0.30) Estimate, Sales $1.61M Beat $1.50M Estimate
Author: Benzinga Newsdesk | August 12, 2024 04:03pm
Spruce Biosciences (NASDAQ:
SPRB) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.30) by 26.67 percent. This is a 31.25 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $1.61 million which beat the analyst consensus estimate of $1.50 million by 7.69 percent. This is a 25.64 percent decrease over sales of $2.17 million the same period last year.
Posted In: SPRB